Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

216
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
216
Cross-reactivity00:42

Cross-reactivity

31.4K
Overview
31.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing dengue vaccination strategies.

PLoS medicine·2026
Same author

Country-level perspectives and priorities to guide the development of Invasive non-Typhoidal Salmonella (iNTS) vaccines: Insights from seven countries.

PLoS neglected tropical diseases·2026
Same author

The invasive non-typhoidal Salmonella vaccine landscape: Innovations and challenges ahead.

Vaccine·2026
Same author

Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines.

Nature communications·2025
Same author

WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever- key considerations and research gaps.

Gates open research·2025
Same author

Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerations.

Vaccine·2025

Related Experiment Video

Updated: Aug 29, 2025

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.4K

Dengue vaccine development: challenges and prospects.

Annelies Wilder-Smith1

  • 1Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Current Opinion in Infectious Diseases
|September 13, 2022
PubMed
Summary
This summary is machine-generated.

Developing effective dengue vaccines faces challenges due to the four distinct serotypes. Second-generation dengue vaccines offer advantages in dosing and composition, but further trials are needed for dengue-naive populations.

More Related Videos

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

32.0K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K

Related Experiment Videos

Last Updated: Aug 29, 2025

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.4K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

32.0K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Dengue vaccine development is a critical global health priority.
  • No dengue vaccine is currently in widespread use, highlighting significant unmet needs.
  • Understanding dengue serotype interactions is key to vaccine efficacy.

Purpose of the Study:

  • To review the challenges in developing dengue vaccines.
  • To present the latest advancements in second-generation dengue vaccine candidates.
  • To assess the current status and future prospects of dengue vaccination strategies.

Main Methods:

  • Review of existing literature on dengue vaccine development.
  • Analysis of immunological challenges posed by dengue serotypes.
  • Evaluation of the characteristics and performance of second-generation vaccines.

Main Results:

  • The primary challenge is the complex immunological interaction between the four dengue serotypes.
  • Second-generation vaccines incorporate nonstructural proteins and require fewer doses.
  • Current vaccines benefit dengue-primed individuals, but a solution for dengue-naive populations is still needed.

Conclusions:

  • Identifying correlates of protection and enhancement is crucial for all dengue vaccines.
  • Second-generation dengue vaccines require completion of Phase 3 trials before widespread use.
  • Imminent release of 5-year efficacy and safety data for second-generation vaccines is anticipated.